Clinical Trial Update: Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov reports a Phase 1/Phase 2 study evaluating Al18F-NOTA-Pentixafor PET/CT for primary aldosteronism, including aldosterone-producing adenoma, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosterone-producing Adenoma
• Aldosteronism

Drugs mentioned

• Al18F-NOTA-Pentixafor (Al18F-NOTA-Pentixafor)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma | Phase 1, Phase 2 | Status: RECRUITING